Edition:
United Kingdom

Concert Pharma Says FDA Granted Fast Track Designation To CTP-543


Friday, 12 Jan 2018 

Jan 12 (Reuters) - Concert Pharmaceuticals Inc ::FDA GRANTS FAST TRACK DESIGNATION TO CONCERT PHARMACEUTICALS’ CTP-543 FOR THE TREATMENT OF ALOPECIA AREATA.CONCERT PHARMA SAYS U.S. FDA GRANTED FAST TRACK DESIGNATION FOR CO'S CTP-543. 

Company Quote

10.58
-0.17 -1.58%
22 Jul 2019